Methods of CD40 activation and immune checkpoint blockade
US11594135B2 · kind B2 · utility
0Cited by
6References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 2, 2016 |
| Grant date | Feb 28, 2023 |
| Priority date | — |
| Expiry date | Jul 29, 2037 |
Classification
- Technology area (CPC H)Electricity
- CPC primaryH04L67/306
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are methods and compositions for treating cancer in an individual comprising administering to the individual an effective amount of at least one immune checkpoint inhibitor and a chimeric CD 154 polypeptide. Also provided herein are methods of enhanced immune function.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.